跳至主要内容
临床试验/ISRCTN57618066
ISRCTN57618066已完成未知

Comparison of gabapentin and memantine as treatment for acquired nystagmus: a double-blind cross-over study with each patient serving as their own control

ational Eye Institute/National Institutes of Health (USA)0 个研究点目标入组 10 人开始时间: 2009年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

2010 results in: https://www.ncbi.nlm.nih.gov/pubmed/20437565 (added 08/08/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with acquired nystagmus due to multiple sclerosis, stroke (brain stem) or cerebellar disease (such as Chiari malformation)
  • 2. Medically stable
  • 3. Able to give informed consent
  • 4. Can understand and cooperate with the testing
  • 5. Aged 18 years or older, both sexes

排除标准

  • 1. Not able to understand or follow the instructions of each protocol
  • 2. Too frail to sit in the vestibular chair during testing for the required period
  • 3. Judged to be at risk for falls (many patients with poor balance adjust to this, and are not at risk of falls)
  • 4. History of mental illness or confusion
  • 5. Known to have an allergy to gabapentin or memantine
  • 6. Pregnant, since the safety of memantine in pregnancy is unknown

研究者

发起方
ational Eye Institute/National Institutes of Health (USA)

相似试验